DSpace Repository

Short Report: Molecular Markers Associated with Plasmodium Falciparum Resistance to Sulfadoxine-Pyrimethamine in the Democratic Republic of Congo.

Show simple item record

dc.contributor Epicentre, Paris, France; Médecins Sans Frontières, Brussels, Belgium; Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium.
dc.creator Cohuet, S
dc.creator Bonnet, M
dc.creator Van Herp, M
dc.creator Van Overmeir, C
dc.creator D'Alessandro, U
dc.creator Guthmann, J P P
dc.date 2006-07
dc.date.accessioned 2017-01-31T07:09:59Z
dc.date.available 2017-01-31T07:09:59Z
dc.identifier Short Report: Molecular Markers Associated with Plasmodium Falciparum Resistance to Sulfadoxine-Pyrimethamine in the Democratic Republic of Congo. 2006, 75 (1):152-4 Am. J. Trop. Med. Hyg.
dc.identifier 0002-9637
dc.identifier 16837723
dc.identifier http://hdl.handle.net/10144/18354
dc.identifier http://fieldresearch.msf.org/msf/handle/10144/18354
dc.identifier The American Journal of Tropical Medicine and Hygiene
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10144/18354
dc.description Sulfadoxine-pyrimethamine (SP) is the first line antimalarial treatment in the Democratic Republic of Congo. Using polymerase chain reaction, we assessed the prevalence of mutations in the dihydrofolate reductase (dhfr) (codons 108, 51, 59) and dihydropteroate synthase (dhps) (codons 437, 540) genes of Plasmodium falciparum, which have been associated with resistance to pyrimethamine and sulfadoxine, respectively. Four hundred seventy-four patients were sampled in Kilwa (N = 138), Kisangani (N = 112), Boende (N = 106), and Basankusu (N = 118). The proportion of triple mutations dhfr varied between sites but was always > 50%. The proportion of dhps double mutations was < 20%, with some sites as low as 0.9%. A quintuple mutation was present in 12.8% (16/125) samples in Kilwa; 11.9% (13/109) in Kisangani, 2.9% (3/102) in Boende, and 0.9% (1/112) in Basankusu. These results suggest high resistance to pyrimethamine alone or combined with sulfadoxine. Adding artesunate to SP does not seem a valid alternative to the current monotherapy.
dc.language en
dc.relation http://www.ajtmh.org
dc.relation http://www.ajtmh.org
dc.rights Archived on this site with the kind permission of the American Society of Tropical Medicine and Hygiene, www.astmh.org
dc.title Short Report: Molecular Markers Associated with Plasmodium Falciparum Resistance to Sulfadoxine-Pyrimethamine in the Democratic Republic of Congo.


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account